Evidence map›Paper›PMID 39375356›Full record

ArticleSchizophrenia (Heidelberg, Germany)2024

Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN.

Margot I E Slot, Maria F Urquijo Castro, Inge Winter-van Rossum, Hendrika H van Hell, Dominic Dwyer, Paola Dazzan, Arija Maat, Lieuwe De Haan, Benedicto Crespo-Facorro, Birte Y Glenthøj and 16 more

Abstract read
In one paragraph

Article in Schizophrenia (Heidelberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Margot I E Slot *Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands. I.E.Slot-3@umcutrecht.nl.ORCID http://orcid.org/0000-0003-0420-6922
Maria F Urquijo Castro *Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.
Inge Winter-van RossumDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Hendrika H van HellDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Dominic DwyerCentre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-3949-5867
Paola DazzanDepartment of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, Denmark 458 Hill, SE5 8AF, London, UK.
Arija MaatDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Lieuwe De HaanAmsterdam UMC, University of Amsterdam, Psychiatry, Department Early Psychosis, Meibergdreef 9, Amsterdam, The Netherlands.
Benedicto Crespo-FacorroDepartment of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL. School of Medicine, University of Cantabria, Santander, Spain.
Birte Y GlenthøjCentre for Neuropsychiatric Schizophrenia Research (CNSR) & Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, Glostrup, Denmark.ORCID http://orcid.org/0000-0003-3056-7262
Stephen M LawrieDivision of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, EH10 5HF, UK.ORCID http://orcid.org/0000-0002-2444-5675
Colm McDonaldCentre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, National University of Ireland Galway, H91 TK33, Galway, Ireland.ORCID http://orcid.org/0000-0003-1661-5192
Oliver GruberSection for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.
Thérèse van AmelsvoortDepartment of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID http://orcid.org/0000-0003-3382-4754
Tilo KircherDepartment of Psychiatry, University of Marburg, Rudolf-Bultmann-Straße 8, D-35039, Marburg, Germany.
Barnaby NelsonCentre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Silvana GalderisiDepartment of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Largo Madonna delle Grazie, 80138, Naples, Italy.ORCID http://orcid.org/0000-0002-1592-7656
Mark WeiserZachai Department of Psychiatry, Sheba Medical Center, Tel Hashomer, 52621, Israel.ORCID http://orcid.org/0000-0003-3638-0271
Gabriele SachsDepartment of Psychiatry and Psychotherapy, 1090, Vienna, Austria.
Matthias KirschnerDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-9486-1439
PSYSCAN Consortium
W Wolfgang FleischhackerMedical University of Innsbruck, Innsbruck, Austria.
Philip McGuireDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4381-0532
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.ORCID http://orcid.org/0000-0001-6825-6262
René S KahnDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands. rene.kahn@mssm.edu.ORCID http://orcid.org/0000-0001-5909-8004

Funding

EC | EC Seventh Framework Programm | FP7 Health (FP7-HEALTH - Specific Programme "Cooperation": Health) 603196
6 · The paper itself

Abstract

Several multivariate prognostic models have been published to predict outcomes in patients with first episode psychosis (FEP), but it remains unclear whether those predictions generalize to independent populations. Using a subset of demographic and clinical baseline predictors, we aimed to develop and externally validate different models predicting functional outcome after a FEP in the context of a schizophrenia-spectrum disorder (FES), based on a previously published cross-validation and machine learning pipeline. A crossover validation approach was adopted in two large, international cohorts (EUFEST, n = 338, and the PSYSCAN FES cohort, n = 226). Scores on the Global Assessment of Functioning scale (GAF) at 12 month follow-up were dichotomized to differentiate between poor (GAF current < 65) and good outcome (GAF current ≥ 65). Pooled non-linear support vector machine (SVM) classifiers trained on the separate cohorts identified patients with a poor outcome with cross-validated balanced accuracies (BAC) of 65-66%, but BAC dropped substantially when the models were applied to patients from a different FES cohort (BAC = 50-56%). A leave-site-out analysis on the merged sample yielded better performance (BAC = 72%), highlighting the effect of combining data from different study designs to overcome calibration issues and improve model transportability. In conclusion, our results indicate that validation of prediction models in an independent sample is essential in assessing the true value of the model. Future external validation studies, as well as attempts to harmonize data collection across studies, are recommended.

Identifiers

PMID39375356
PMCPMC11458815

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.